No Benefit Seen for Beta Blockers in Some Heart Attack Patients

No Benefit Seen for Beta Blockers in Some Heart Attack Patients

Although beta blockers are usually given to patients following a heart attack, a new study indicates that the drugs do not help them live any longer than those not on the medications.

Beta blockers work to lower the activity of the heart as well as lower blood pressure. They are required after a heart attack when the event is accompanied by heart failure, where the heart is permanently damaged. However, many heart attacks do not involve this failure, yet many of those patients are still prescribed beta blockers.

Researchers focused on data regarding 179,000 patients who suffered a heart attack without heart failure. After a year following the heart attack, there was no difference in the death rates between those prescribed a beta blocker and those who were not, the researchers reported in the Journal of the American College of Cardiology.

Beta blockers are associated with a host of side effects, including more serious ones such as shortness of breath, dizziness, trouble sleeping and depression. Commonly prescribed drugs in this class include Lopressor and Toprol XL (metoprolol) Coreg (carvedilol) and Brevibloc (esmolol).

The study questions whether beta blockers should be prescribed at all to those who have had a heart attack but did not suffer heart failure.

“This study suggests that there may be no mortality advantage associated with the prescription of beta-blockers for patients with heart attack and no heart failure,” Chris Gale, MD, a cardiologist at the University of Leeds (UK), who worked on the study, said in a statement. “A necessary next step is the investigation of beta-blockers in this population in a randomized controlled trial.”


Jonathan Block

Jonathan Block

Jonathan Block is MedShadow's content editor. He has previously worked for Psychiatry Advisor, Modern Healthcare, Health Reform Week and The Pink Sheet.


Did you find this article helpful?


Latest News

News Scan: Warfarin, A-Fib, Lavender Oil and Dopamine Agonist Medicine

News Scan: Warfarin, A-Fib, Lavender Oil and Dopamine Agonist Medicine

Every so often a lay person like me slaps her forehead and says out loud, “what took so long?” A veggie works better than a medicine, why not use the veggie? Talking to patients in their home leads to better understanding by the patients? Of course. And less intuitive but…

News Scan 9/4/2019: Breast Cancer, Osteoporosis and Cardio Health

News Scan 9/4/2019: Breast Cancer, Osteoporosis and Cardio Health

Less medicine and a little less food are the themes for keeping healthy this week.  Be well.    Breast Cancer and Hormone Treatment In a large study of published studies (meta analysis) that included more than 100,000 women, those who reported ever using MHT had a 26% higher relative risk…